Carmen Charlton
- Infectious Diseases top 5%
- Molecular Biology
- Epidemiology top 10%
- Clinical Biochemistry top 5%
- Biomedical Engineering
- Co-authors
- Romney M. HumphriesApril M. BobenchikJanet A. HindlerJamil N. KanjiEszter DeákSabrina S. PlittGerald F. AudetteRobert S. Hodges
- Topics
- SARS-CoV-2 and COVID-19 Research (12 papers)SARS-CoV-2 detection and testing (12 papers)Hepatitis C virus research (9 papers)
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
Carmen Charlton
64 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 136
- Infectious Diseases 503
- Molecular Biology 327
- Epidemiology 273
- Clinical Biochemistry 133
- Biomedical Engineering 131
Countries citing papers authored by Carmen Charlton
This map shows the geographic impact of Carmen Charlton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carmen Charlton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carmen Charlton more than expected).
Fields of papers citing papers by Carmen Charlton
This network shows the impact of papers produced by Carmen Charlton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carmen Charlton. The network helps show where Carmen Charlton may publish in the future.
Co-authorship network of co-authors of Carmen Charlton
This figure shows the co-authorship network connecting the top 25 collaborators of Carmen Charlton. A scholar is included among the top collaborators of Carmen Charlton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carmen Charlton. Carmen Charlton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 2 | |
| 5 | 1 | |
| 6 | 39 | |
| 7 | 5 | |
| 8 | 0 | |
| 9 | 4 | |
| 10 | 16 | |
| 11 | 11 | |
| 12 | 10 | |
| 13 | 3 | |
| 14 | 6 | |
| 15 | 15 | |
| 16 | 5 | |
| 17 | 12 | |
| 18 | 53 | |
| 19 | The fight against vaccination: the Leicester demonstration of 1885. | 2 |
| 20 | 0 |
About Carmen Charlton
Carmen Charlton is a scholar working on Infectious Diseases, Virology and Hepatology, having authored 71 papers that have together received 1.2k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (12 papers), SARS-CoV-2 detection and testing (12 papers) and Hepatitis C virus research (9 papers). The work is most often cited by research in Infectious Diseases (503 citations), Molecular Medicine (114 citations) and Clinical Biochemistry (133 citations). Carmen Charlton has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Romney M. Humphries, April M. Bobenchik, Janet A. Hindler, Jamil N. Kanji, Eszter Deák, Sabrina S. Plitt, Gerald F. Audette, Robert S. Hodges, Erin J. van Schaik and Randall T. Irvin. Their work appears in journals such as Journal of Biological Chemistry, PLoS ONE and Clinical Microbiology Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.